Press release article from our research archive:

BASF Venture Capital invests in biotechnology company Sciona Inc; Innovative genetic tests aim to enhance personalized nutrition.

M2 PRESSWIRE-20 September 2004-BASF GROUP: BASF Venture Capital invests in biotechnology company Sciona Inc; Innovative genetic tests aim to enhance personalized nutrition(C)1994-2004 M2 COMMUNICATIONS LTD

RDATE:09202004

BASF Venture Capital GmbH, Ludwigshafen, is investing in the biotechnology company Sciona Inc., which is based in New Haven, Connecticut (U.S.). Sciona develops genetic tests that help people match nutrition and lifestyle choices to their individual genetic profiles. In addition to BASF Venture Capital, which is investing $1.1 million, companies such as the U.S. venture capital fund Burrill & Co. as the lead investor, as well as the specialty chemical ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!